Tomoko Toyota

Wako, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 56 publications

A case of bipolar I disorder with a loss-of-function variant of schizophrenia risk gene SETD1A: possible expansion of the relevant clinical spectrum supported by a meta-analysis.

A case of bipolar I disorder with a loss-of-function variant of schizophrenia risk gene SETD1A: possible expansion of the relevant clinical spectrum supported by a meta-analysis.

Journal: Psychiatry and clinical neurosciences

Published: November 29, 2023

Cross-Disorder Analysis of Genic and Regulatory Copy Number Variations in Bipolar Disorder, Schizophrenia, and Autism Spectrum Disorder.

Cross-Disorder Analysis of Genic and Regulatory Copy Number Variations in Bipolar Disorder, Schizophrenia, and Autism Spectrum Disorder.

Journal: Biological psychiatry

Published: October 29, 2021

Differential genetic associations and expression of PAPST1/SLC35B2 in bipolar disorder and schizophrenia.

Differential genetic associations and expression of PAPST1/SLC35B2 in bipolar disorder and schizophrenia.

Journal: Journal of neural transmission (Vienna, Austria : 1996)

Published: September 23, 2021

Role of an Atypical Cadherin Gene, Cdh23 in Prepulse Inhibition, and Implication of CDH23 in Schizophrenia.

Role of an Atypical Cadherin Gene, Cdh23 in Prepulse Inhibition, and Implication of CDH23 in Schizophrenia.

Journal: Schizophrenia bulletin

Published: February 17, 2021

A loss-of-function variant in SUV39H2 identified in autism-spectrum disorder causes altered H3K9 trimethylation and dysregulation of protocadherin β-cluster genes in the developing brain.

A loss-of-function variant in SUV39H2 identified in autism-spectrum disorder causes altered H3K9 trimethylation and dysregulation of protocadherin β-cluster genes in the developing brain.

Journal: Molecular psychiatry

Published: January 27, 2021

LDB2 locus disruption on 4p16.1 as a risk factor for schizophrenia and bipolar disorder.

LDB2 locus disruption on 4p16.1 as a risk factor for schizophrenia and bipolar disorder.

Journal: Human genome variation

Published: July 13, 2020

Peroxisome proliferator-activated receptor α as a novel therapeutic target for schizophrenia.

Peroxisome proliferator-activated receptor α as a novel therapeutic target for schizophrenia.

Journal: EBioMedicine

Published: July 02, 2020

Genetic risks of schizophrenia identified in a matched case-control study.

Genetic risks of schizophrenia identified in a matched case-control study.

Journal: European archives of psychiatry and clinical neuroscience

Published: May 09, 2020

A recurrent PJA1 variant in trigonocephaly and neurodevelopmental disorders.

A recurrent PJA1 variant in trigonocephaly and neurodevelopmental disorders.

Journal: Annals of clinical and translational neurology

Published: April 25, 2020

Cooperation of LIM domain-binding 2 (LDB2) with EGR in the pathogenesis of schizophrenia.

Cooperation of LIM domain-binding 2 (LDB2) with EGR in the pathogenesis of schizophrenia.

Journal: EMBO molecular medicine

Published: April 22, 2020

VLDL-specific increases of fatty acids in autism spectrum disorder correlate with social interaction.

VLDL-specific increases of fatty acids in autism spectrum disorder correlate with social interaction.

Journal: EBioMedicine

Published: April 20, 2020

Lipid Pathology of the Corpus Callosum in Schizophrenia and the Potential Role of Abnormal Gene Regulatory Networks with Reduced Microglial Marker Expression.

Lipid Pathology of the Corpus Callosum in Schizophrenia and the Potential Role of Abnormal Gene Regulatory Networks with Reduced Microglial Marker Expression.

Journal: Cerebral cortex (New York, N.Y. : 1991)

Published: April 02, 2020

Showing 1-12 of 56

Last Updated: 09/26/2026